ea0029p324 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012
Mokhort T.
, Tsapaeva N.
, Buko I.
, Konstantinova E.
, Shyshko O.
Myeloperoxidase (MPO), an enzyme of the innate immune system, exhibits pro-atherogenic effects and includes influence on oxidative damage to LDL- and HDL-cholesterol, and promotion of endothelial dysfunction.The aim: To investigate the disturbance of MPO in type 2 diabetic (T2D) patients depending on intensity of atherosclerosisMaterial and methods: We investigated 244 patients aged from 45 to 60 years (M±SD 54.0±4.63) in...